Richard J Soucier1, P Elliott Miller1, Joseph J Ingrassia2, Ralph Riello3, Nihar R Desai1,4, Tariq Ahmad5. 1. Sections of Cardiovascular Medicine, Yale University School of Medicine, 135 College Street, Suite 230, New Haven, CT, 06520, USA. 2. Division of Cardiology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, 06032, USA. 3. Division of Pharmacy, Yale University School of Medicine, New Haven, CT, USA. 4. Center for Outcomes Research and Evaluation, Yale New Haven Health System, Yale New Haven Hospital, New Haven, CT, USA. 5. Sections of Cardiovascular Medicine, Yale University School of Medicine, 135 College Street, Suite 230, New Haven, CT, 06520, USA. tariq.ahmad@yale.edu.
Abstract
PURPOSE OF REVIEW: Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Several national policy initiatives have focused on improving the quality of heart failure care, including reducing readmissions following hospitalization, which are common, costly, and, at least in part, preventable. The transition from inpatient to ambulatory care setting and the immediate post-hospitalization period present an opportunity to further optimize guideline concordant medical therapy, identify reversible issues related to worsening heart failure, and evaluate prognosis. It can also provide opportunities for medication reconciliation and optimization, consideration of device-based therapies, appropriate management of comorbidities, identification of individual barriers to care, and a discussion of goals of care based on prognosis. RECENT FINDINGS: Recent studies suggest that attention to detail regarding patient comorbidities, barriers to care, optimization of both diuretic and neurohormonal therapies, and assessment of prognosis improve patient outcomes. Despite the fact that the transition period appears to be an optimal time to address these issues in a comprehensive manner, most patients are not referred to programs specializing in this approach post hospital discharge. The objective of this review is to provide an outline for early post discharge care that allows clinicians and other health care providers to care for these heart failure patients in a manner that is both firmly rooted in the guidelines and patient-centered. Data regarding which intervention is most likely to confer benefit to which subset of patients with this disease is lacking and warrants further study.
PURPOSE OF REVIEW: Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Several national policy initiatives have focused on improving the quality of heart failure care, including reducing readmissions following hospitalization, which are common, costly, and, at least in part, preventable. The transition from inpatient to ambulatory care setting and the immediate post-hospitalization period present an opportunity to further optimize guideline concordant medical therapy, identify reversible issues related to worsening heart failure, and evaluate prognosis. It can also provide opportunities for medication reconciliation and optimization, consideration of device-based therapies, appropriate management of comorbidities, identification of individual barriers to care, and a discussion of goals of care based on prognosis. RECENT FINDINGS: Recent studies suggest that attention to detail regarding patient comorbidities, barriers to care, optimization of both diuretic and neurohormonal therapies, and assessment of prognosis improve patient outcomes. Despite the fact that the transition period appears to be an optimal time to address these issues in a comprehensive manner, most patients are not referred to programs specializing in this approach post hospital discharge. The objective of this review is to provide an outline for early post discharge care that allows clinicians and other health care providers to care for these heart failurepatients in a manner that is both firmly rooted in the guidelines and patient-centered. Data regarding which intervention is most likely to confer benefit to which subset of patients with this disease is lacking and warrants further study.
Entities:
Keywords:
Chronic care; Clinic management; Decompensated heart failure; GDMT; HF diagnostics; Heart failure; Readmission; Transitions of care
Authors: Dennis T Ko; David A Alter; Peter C Austin; John J You; Douglas S Lee; Feng Qiu; Therese A Stukel; Jack V Tu Journal: Am Heart J Date: 2008-02 Impact factor: 4.749
Authors: Ankur Gupta; Larry A Allen; Deepak L Bhatt; Margueritte Cox; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Eric D Peterson; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow Journal: JAMA Cardiol Date: 2018-01-01 Impact factor: 14.676
Authors: William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav Journal: Lancet Date: 2011-02-19 Impact factor: 79.321
Authors: Kumar Dharmarajan; Yongfei Wang; Zhenqiu Lin; Sharon-Lise T Normand; Joseph S Ross; Leora I Horwitz; Nihar R Desai; Lisa G Suter; Elizabeth E Drye; Susannah M Bernheim; Harlan M Krumholz Journal: JAMA Date: 2017-07-18 Impact factor: 56.272
Authors: Erin K Donaho; Andrea C Hall; Jennifer A Gass; Macarthur A Elayda; Vei-Vei Lee; Shreda Paire; Deborah E Meyers Journal: J Am Heart Assoc Date: 2015-12-23 Impact factor: 5.501
Authors: Paweł Krzesiński; Janusz Siebert; Ewa Anita Jankowska; Agata Galas; Katarzyna Piotrowicz; Adam Stańczyk; Paweł Siwołowski; Piotr Gutknecht; Paweł Chrom; Piotr Murawski; Andrzej Walczak; Dominika Szalewska; Waldemar Banasiak; Piotr Ponikowski; Grzegorz Gielerak Journal: ESC Heart Fail Date: 2021-01-18
Authors: Marat Fudim; Sabina Sayeed; Haolin Xu; Roland A Matsouaka; Paul A Heidenreich; Eric J Velazquez; Clyde W Yancy; Gregg C Fonarow; Adrian F Hernandez; Adam D DeVore Journal: Circ Heart Fail Date: 2020-04-06 Impact factor: 8.790